BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis

BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosisBCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis, Published online: 01 June 2018; doi:10.1038/s41388-018-0212-5BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis

https://www.nature.com/articles/s41388-018-0212-5

Source: Oncogene - June 1, 2018 Category: Cancer & Oncology Authors: Ulrike Heinicke Tinka Haydn Sarah Kehr Meike Vogler Simone Fulda Source Type: research

More News: Rhabdomyosarcoma